BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36151757)

  • 1. Liver cancer concurrent with chronic myelocytic leukemia and extreme thrombocytosis: a rare case report.
    Han P; Han ZQ; Mao X; Wang J; Li QL; Xiao M; Meng L; Tian DA; Hong ZY
    J Int Med Res; 2022 Sep; 50(9):3000605221123684. PubMed ID: 36151757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
    Ahn S; Park JS; Han JH; Cho SR
    Ann Lab Med; 2015 May; 35(3):370-2. PubMed ID: 25932449
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
    Cesar JM; Cabello P; Ferro T; Navarro JL
    Cancer Genet Cytogenet; 2006 May; 167(1):74-7. PubMed ID: 16682291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myeloid leukemia onset with marked thrombocythemia].
    Shen Q; Zhou JW; Zhu GR; Yang YY; Qiu HR; Zhu GR; Xia W; Jiang PJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):247-51. PubMed ID: 16638190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.
    Campbell LJ; Patsouris C; Rayeroux KC; Somana K; Januszewicz EH; Szer J
    Cancer Genet Cytogenet; 2002 Nov; 139(1):30-3. PubMed ID: 12547154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
    Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
    Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL. (+) without splenomegaly: A case report.
    Rajabto W; Angkasa YK
    Niger J Clin Pract; 2022 Mar; 25(3):373-375. PubMed ID: 35295063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
    Kawano N; Okuda S; Yoshida S; Kugimiya H; Ito M; Horikawa N; Chosa N; Hisakata T; Fukudome T; Sakurai R; Yamashita K; Ueda A; Kanda Y
    Int J Hematol; 2011 Dec; 94(6):561-6. PubMed ID: 22057509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib (ST1571) provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes.
    Jiang G; Yang F; Li M; Weissbecker K; Price S; Kim KC; La Russa VF; Safah H; Ehrlich M
    Cancer Biol Ther; 2003; 2(1):103-8. PubMed ID: 12673129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression.
    Akram AM; Iqbal Z; Akhtar T; Khalid AM; Sabar MF; Qazi MH; Aziz Z; Sajid N; Aleem A; Rasool M; Asif M; Aloraibi S; Aljamaan K; Iqbal M
    Cancer Biol Ther; 2017 Apr; 18(4):214-221. PubMed ID: 28278078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients.
    Hailemariam TS; Mehdi M; Kinde S; Seifu D; Edao A
    Recent Pat Anticancer Drug Discov; 2021; 16(3):445-455. PubMed ID: 33618649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL positive essential thrombocythaemia: a variant of chronic myelogerous leukaemia or a distinct clinical entity: a special case report.
    Fadilah SA; Cheong SK
    Singapore Med J; 2000 Dec; 41(12):595-8. PubMed ID: 11296785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.
    Stella S; Tirró E; Massimino M; Vitale SR; Russo S; Pennisi MS; Puma A; Romano C; DI Gregorio S; Innao V; Stagno F; DI Raimondo F; Musolino C; Manzella L
    In Vivo; 2019; 33(5):1593-1598. PubMed ID: 31471409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.
    Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R
    Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
    Voskaridou E; Terpos E; Komninaka V; Eftyhiadis E; Mantzourani M; Loukopoulos D
    Br J Haematol; 2002 Jan; 116(1):155-7. PubMed ID: 11841409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.